Skip to content

Clinical trials

Phase 3 Wound Infection trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wound Infection Phase: Phase 3 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20112
20121
20141
20161
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Durata Therapeutics Inc., an affiliate of Allergan plc3
Major Extremity Trauma Research Consortium2
Melinta Therapeutics, Inc.2
Massachusetts General Hospital1
Pfizer1
Richmond University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wound Infection10
Cellulitis6
Abscess5
Surgical Wound Infection4
Bacterial Infections1
Fractures, Bone1
Fractures, Open1
Fractures, Ununited1
Infections1
Inflammation1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.